FDA Approved: PREMARIN VAGINAL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approved a supplemental application for Premarin Vaginal (conjugated estrogens) to update the product's labeling under Wyeth Pharmaceuticals (Pfizer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genitourinary Syndrome of Menopause
• Vulvar and Vaginal Atrophy

Drugs mentioned

• PREMARIN VAGINAL (Conjugated estrogens)

Snippet

SUPPL AP for PREMARIN VAGINAL (CONJUGATED ESTROGENS)